Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients

M. Aldea; L. Cerbone; A. Bayle; C. Parisi; C. Sarkozy; D. Vasseur; L. Verlingue; F. Blanc-Durand; F. Mosele; M. Sakkal; S. Ponce; P. Lavaud; Y. Loriot; A. Hollebecque; C. Massard; J. C. Soria; L. Lacroix; E. Rouleau; A. Italiano

doi:10.1016/j.annonc.2021.09.002

Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients

M. Aldea, L. Cerbone, A. Bayle, C. Parisi, C. Sarkozy, D. Vasseur, L. Verlingue, F. Blanc-Durand, F. Mosele, M. Sakkal, S. Ponce, P. Lavaud, Y. Loriot, A. Hollebecque, C. Massard, J. C. Soria, L. Lacroix, E. Rouleau, A. Italiano

Résultats de recherche: Contribution à un journal › Letter › Revue par des pairs

8 Citations (Scopus)

langue originale	Anglais
Pages (de - à)	1642-1645
Nombre de pages	4
journal	Annals of Oncology
Volume	32
Numéro de publication	12
Les DOIs	https://doi.org/10.1016/j.annonc.2021.09.002
état	Publié - 1 déc. 2021

Accès au document

10.1016/j.annonc.2021.09.002

Autres fichiers et liens

Lien vers la publication dans Scopus

Contient cette citation

Aldea, M., Cerbone, L., Bayle, A., Parisi, C., Sarkozy, C., Vasseur, D., Verlingue, L., Blanc-Durand, F., Mosele, F., Sakkal, M., Ponce, S., Lavaud, P., Loriot, Y., Hollebecque, A., Massard, C., Soria, J. C., Lacroix, L., Rouleau, E., & Italiano, A. (2021). Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients. Annals of Oncology, 32(12), 1642-1645. https://doi.org/10.1016/j.annonc.2021.09.002

@article{3fc07cc8a1a340a99eefa37e6dcdfa04,

title = "Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients",

author = "M. Aldea and L. Cerbone and A. Bayle and C. Parisi and C. Sarkozy and D. Vasseur and L. Verlingue and F. Blanc-Durand and F. Mosele and M. Sakkal and S. Ponce and P. Lavaud and Y. Loriot and A. Hollebecque and C. Massard and Soria, {J. C.} and L. Lacroix and E. Rouleau and A. Italiano",

note = "Funding Information: None declared. Dr Italiano is a member of advisory boards for Bayer, Roche, Springworks, IPSEN, Daiichy Sankyo, and GSK; he has received research grants from Bayer, Roche, Astra Zeneca, Epizyme, and Merck. The other authors have no disclosures.",

year = "2021",

month = dec,

day = "1",

doi = "10.1016/j.annonc.2021.09.002",

language = "English",

volume = "32",

pages = "1642--1645",

journal = "Annals of Oncology",

issn = "0923-7534",

number = "12",

}

Aldea, M, Cerbone, L, Bayle, A, Parisi, C, Sarkozy, C, Vasseur, D, Verlingue, L, Blanc-Durand, F, Mosele, F, Sakkal, M, Ponce, S, Lavaud, P, Loriot, Y, Hollebecque, A, Massard, C, Soria, JC, Lacroix, L, Rouleau, E & Italiano, A 2021, 'Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients', Annals of Oncology, VOL. 32, Numéro 12, p. 1642-1645. https://doi.org/10.1016/j.annonc.2021.09.002

TY - JOUR

T1 - Detection of additional occult malignancy through profiling of ctDNA in late-stage cancer patients

AU - Aldea, M.

AU - Cerbone, L.

AU - Bayle, A.

AU - Parisi, C.

AU - Sarkozy, C.

AU - Vasseur, D.

AU - Verlingue, L.

AU - Blanc-Durand, F.

AU - Mosele, F.

AU - Sakkal, M.

AU - Ponce, S.

AU - Lavaud, P.

AU - Loriot, Y.

AU - Hollebecque, A.

AU - Massard, C.

AU - Soria, J. C.

AU - Lacroix, L.

AU - Rouleau, E.

AU - Italiano, A.

N1 - Funding Information: None declared. Dr Italiano is a member of advisory boards for Bayer, Roche, Springworks, IPSEN, Daiichy Sankyo, and GSK; he has received research grants from Bayer, Roche, Astra Zeneca, Epizyme, and Merck. The other authors have no disclosures.

PY - 2021/12/1

Y1 - 2021/12/1

UR - http://www.scopus.com/inward/record.url?scp=85119401580&partnerID=8YFLogxK

U2 - 10.1016/j.annonc.2021.09.002

DO - 10.1016/j.annonc.2021.09.002

M3 - Letter

C2 - 34509616

AN - SCOPUS:85119401580

SN - 0923-7534

VL - 32

SP - 1642

EP - 1645

JO - Annals of Oncology

JF - Annals of Oncology

IS - 12

ER -